NCT05051046 Colorectal Cancer Screnning Colonoscopy Under Hypnosis
| NCT ID | NCT05051046 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Tours |
| Condition | Colorectal (Colon or Rectal) Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 600 participants |
| Start Date | 2022-01-31 |
| Primary Completion | 2028-02-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 600 participants in total. It began in 2022-01-31 with a primary completion date of 2028-02-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Through this study, the effectiveness of hypnosis in the realization of a colonoscopy for the detection of colorectal cancer will be evaluated
Eligibility Criteria
Inclusion Criteria: * Patients 18 years of age or older * Undergoing a screening colonoscopy (mass screening Fecal Immunochemical Test positive or as an individual (family history of colon cancer or adenoma, personal history of adenoma, cancer, chronic inflammatory bowel disease) or in the context of a transit disorder, hemorrhage or anemia * Affiliated with a French social security system * Having signed a written consent Exclusion Criteria: * Patient requiring emergency colonoscopy * History of colonic resection * Carriers of behavioral disorders and/or psychiatric illness * Limited cognitive abilities making it impossible to read or fill out a discrete choice questionnaire (language problems, comprehension problems) * Contraindication to hypnosis, preventing quality interaction (comprehension and/or language problems, hearing impairment) * Contraindication to general anesthesia * Under a legal protection regime * Pregnant or breastfeeding woman
Contact & Investigator
Driffa MOUSSATA, PhD
PRINCIPAL INVESTIGATOR
University Hospital Center of Tours
Frequently Asked Questions
Who can join the NCT05051046 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Colorectal (Colon or Rectal) Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05051046 currently recruiting?
Yes, NCT05051046 is actively recruiting participants. Contact the research team at D.MOUSSATA@chu-tours.fr for enrollment information.
Where is the NCT05051046 trial being conducted?
This trial is being conducted at Angers, France.
Who is sponsoring the NCT05051046 clinical trial?
NCT05051046 is sponsored by University Hospital, Tours. The principal investigator is Driffa MOUSSATA, PhD at University Hospital Center of Tours. The trial plans to enroll 600 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.